Synapse - Breast Medicine Service

Results (4119)

ACR Appropriateness Criteria® Imaging of Ductal Carcinoma in Situ (DCIS)

Guidelines

Kuzmiak, C. M.; Sharpe, R. E. Jr; Lewin, A. A.; Weinstein, S. P.; Blinder, V.; Dibble, E. H.; Dodelzon, K.; Dogan, B. E.; Paulis, L. V.; Plichta, J. K.; more...
Journal of the American College of Radiology (2025)

Fulltext@MSK | Save

Impact of clonal hematopoiesis on solid tumor progression following radiation therapy

Journal Article

Tao, J. J.; Setton, J.; Vela, P. S.; Safonov, A. M.; Comen, E. A.; Braunstein, L. Z.; Reis-Filho, J. S.; Riaz, N.; Powell, S. N.; Levine, R. L.; more...
JCO Precision Oncology (2025)

Fulltext@MSK | Save

First-in-human study of FAZ053, an anti-programmed death-ligand 1 (anti-PD-L1) monoclonal antibody, alone and in combination with spartalizumab, in patients with advanced malignancies

Journal Article

Janku, F.; Tan, D. S. P.; Martin-Liberal, J.; Takahashi, S.; Geva, R.; Gucalp, A.; Razak, A.; Kan, R.; Reiners, R.; Mataraza, J.; more...
ESMO Open (2025)

Fulltext@MSK | Save

Tumorigenesis driven by BRAF(V600E) requires secondary mutations that overcome its feedback inhibition of RAC1 and migration

Journal Article

Gadal, S.; Boyer, J. A.; Roy, S. F.; Outmezguine, N. A.; Sharma, M.; Li, H.; Fan, N.; Chan, E.; Romin, Y.; Barlas, A.; more...
Cancer Research (2025)

Fulltext@MSK | Save

Expert consensus on treating HR+/HER2-metastatic breast cancer based on real-world practice patterns observed in the RETRACT survey of US oncologists

Journal Article

Rugo, H. S.; Bardia, A.; Gradishar, W. J.; Hamilton, E. P.; Hurvitz, S. A.; Jhaveri, K.; Mahtani, R.; Tolaney, S. M.
Breast (2025)

Fulltext@MSK | Save

Genomic and transcriptomic profiling of primary tumors from patients with HR+, HER2-, node-positive, high-risk early breast cancer (EBC) in the monarchE trial

Meeting Abstract

Rubenstein, C. S.; Turner, N.; Reis, J. S.; Goetz, M. P.; Desmedt, C.; Chandarlapaty, S.; Sasano, H.; Arteaga, C. L.; Loi, S.; Graff, S. L.; more...
Breast (2025)

Fulltext@MSK | Save

Prognostic utility of ctDNA detection in the monarchE trial of adjuvant abemaciclib plus endocrine therapy (ET) in HR+, HER2-, node-positive, high-risk early breast cancer (EBC)

Meeting Abstract

Loi, S.; Johnston, S.; Arteaga, C.; Graff, S.; Chandarlapaty, S.; Goetz, M.; Desmedt, C.; Sasano, H.; Liu, D.; Rodrik-Outmezguine, V.; more...
Breast (2025)

Fulltext@MSK | Save

Co-occurrence of PI3K pathway gene alterations in endometrial cancer molecular subtypes at the single cell level

Meeting Abstract

Da Cruz Paula, A.; Zhu, Y.; Brown, D.; Pareja, F.; de Oliveira, T. B.; Dopeso, H.; da Silva, E. M.; Chandarlapaty, S.; Abu-Rustum, N.; Reis, J.; more...
Laboratory Investigation (2025)

Fulltext@MSK | Save

Germline genetic alterations in homologous recombination deficiency/DNA damage response genes in breast cancer

Meeting Abstract

Keske, A.; Terraf, P.; Gazzo, A.; Repetto, M.; Schwartz, C.; Ross, D.; Zhang, H.; Chandarlapaty, S.; Wen, H.; Brogi, E.; more...
Laboratory Investigation (2025)

Fulltext@MSK | Save

Artificial intelligence to enhance precision medicine in cardio-oncology: A scientific statement from the American Heart Association

Guidelines

Khera, R.; Asnani, A. H.; Krive, J.; Addison, D.; Zhu, H.; Vasbinder, A.; Fleming, M. R.; Arnaout, R.; Razavi, P.; Okwuosa, T. M.; more...
Circulation-Genomic and Precision Medicine (2025)

Fulltext@MSK | Save